Liu Y - Search Results

1

Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression.

Liu Y, Tang W, Ren L, Liu T, Yang M, Wei Y, Chen Y, Ji M, Chen G, Chang W, Xu J. Liu Y, et al. Among authors: liu t. J Transl Med. 2022 Mar 3;20(1):106. doi: 10.1186/s12967-022-03308-8. J Transl Med. 2022. PMID: 35241106 Free PMC article.

2

Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases.

Tang W, Liu Y, Ji M, Liu T, Chen Y, Zhuang A, Mao Y, Chang W, Wei Y, Ren L, Xu J. Tang W, et al. Among authors: liu y, liu t. Ann Surg Oncol. 2022 Jun;29(6):3593-3603. doi: 10.1245/s10434-021-11302-5. Epub 2022 Mar 17. Ann Surg Oncol. 2022. PMID: 35301609

3

Correction to: Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases.

Tang W, Liu Y, Ji M, Liu T, Chen Y, Zhuang A, Mao Y, Chang W, Wei Y, Ren L, Xu J. Tang W, et al. Among authors: liu y, liu t. Ann Surg Oncol. 2022 Nov;29(12):7937. doi: 10.1245/s10434-022-12051-9. Ann Surg Oncol. 2022. PMID: 35751008 No abstract available.

4

The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer.

Liu T, Tang W, Chen Y, Liu Y, Xu D, Jiang Y, Zhou S, Qin X, Ren L, Chang W, Xu J. Liu T, et al. Among authors: liu y. Clin Med Insights Oncol. 2022 Jul 23;16:11795549221104441. doi: 10.1177/11795549221104441. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 35898390 Free PMC article.

5

Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study.

Xu D, Liu Y, Tang W, Xu L, Liu T, Jiang Y, Zhou S, Qin X, Li J, Zhao J, Ye L, Chang W, Xu J. Xu D, et al. Among authors: liu y, liu t. Front Oncol. 2022 Mar 30;12:838870. doi: 10.3389/fonc.2022.838870. eCollection 2022. Front Oncol. 2022. PMID: 35433423 Free PMC article.

6

Preoperative transarterial chemoembolization with drug-eluting beads (DEB-TACE) in patients undergoing conversional hepatectomy: a propensity-score matching analysis.

Liu Y, Zhou B, Tang W, Xu D, Yan Z, Ren L, Zhu D, He G, Wei Y, Chang W, Xu J. Liu Y, et al. Eur Radiol. 2023 Feb;33(2):1022-1030. doi: 10.1007/s00330-022-09063-0. Epub 2022 Sep 6. Eur Radiol. 2023. PMID: 36066736

7

Liposome-Based Carbohydrate Vaccine for Simultaneously Eliciting Humoral and Cellular Antitumor Immunity.

Yao L, Wu L, Wang R, Liu Y, Luo F, Zhang Y, Chen G. Yao L, et al. Among authors: liu y. ACS Macro Lett. 2022 Aug 16;11(8):975-981. doi: 10.1021/acsmacrolett.2c00291. Epub 2022 Jul 14. ACS Macro Lett. 2022. PMID: 35833848

8

Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.

Wang W, Yang L, Hu L, Li F, Ren L, Yu H, Liu Y, Xia L, Lei H, Liao Z, Zhou F, Xie C, Zhou Y. Wang W, et al. Among authors: liu y. PLoS One. 2013 May 31;8(5):e64660. doi: 10.1371/journal.pone.0064660. Print 2013. PLoS One. 2013. PMID: 23741361 Free PMC article.

9

LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.

Wei W, Liu Y, Lu Y, Yang B, Tang L. Wei W, et al. Among authors: liu y. J Cell Biochem. 2017 Oct;118(10):3349-3358. doi: 10.1002/jcb.25988. Epub 2017 May 3. J Cell Biochem. 2017. PMID: 28295543

10

Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.

Liu Y, Han L, Bai Y, Du W, Yang B. Liu Y, et al. Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):206-210. doi: 10.1080/21691401.2017.1304551. Epub 2017 Apr 4. Artif Cells Nanomed Biotechnol. 2018. PMID: 28376685 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,210 results

Search Page

Filters